Načítá se...

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma

PURPOSE: Vaccination with hybridoma-derived autologous tumor immunoglobulin (Ig) idiotype (Id) conjugated to keyhole limpet hemocyanin (KLH) and administered with granulocyte-monocyte colony-stimulating factor (GM-CSF) induces follicular lymphoma (FL) –specific immune responses. To determine the cli...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schuster, Stephen J., Neelapu, Sattva S., Gause, Barry L., Janik, John E., Muggia, Franco M., Gockerman, Jon P., Winter, Jane N., Flowers, Christopher R., Nikcevich, Daniel A., Sotomayor, Eduardo M., McGaughey, Dean S., Jaffe, Elaine S., Chong, Elise A., Reynolds, Craig W., Berry, Donald A., Santos, Carlos F., Popa, Mihaela A., McCord, Amy M., Kwak, Larry W.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2011
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139394/
https://ncbi.nlm.nih.gov/pubmed/21632504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.3005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!